These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 37664913)
1. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231. Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913 [TBL] [Abstract][Full Text] [Related]
2. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint. Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028 [TBL] [Abstract][Full Text] [Related]
3. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis. Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117 [TBL] [Abstract][Full Text] [Related]
4. Disulfiram-Copper Potentiates Anticancer Efficacy of Standard Chemo-therapy Drugs in Bladder Cancer Animal Model through ROS-Autophagy-Ferroptosis Signalling Cascade. Sharma N; Dey S; Singh S; Kumar S; Konar M; Naithani P; Panwar R; Rastogi P; Kakkar A; Mavuduru RS; Pattanaik S Curr Cancer Drug Targets; 2024 Sep; ():. PubMed ID: 39323342 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993 [TBL] [Abstract][Full Text] [Related]
7. SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation. He G; Zhang Y; Feng Y; Chen T; Liu M; Zeng Y; Yin X; Qu S; Huang L; Ke Y; Liang L; Yan J; Liu W J Cell Mol Med; 2024 Apr; 28(7):e18212. PubMed ID: 38516826 [TBL] [Abstract][Full Text] [Related]
8. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes. Li H; Li Y; Yu Y; Ren X; Yang C; Jin W; Li K; Zhou Y; Wu C; Shen Y; Hu W; Liu Y; Yu L; Tong X; Du J; Wang Y Free Radic Biol Med; 2024 Sep; 222():130-148. PubMed ID: 38866192 [TBL] [Abstract][Full Text] [Related]
9. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells. Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585 [TBL] [Abstract][Full Text] [Related]
10. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions. Yang Y; Zhang K; Wang Y; Li M; Sun X; Liang Z; Wang L; Chen L; Yang H; Zhu L Scanning; 2016 Nov; 38(6):825-836. PubMed ID: 27353661 [TBL] [Abstract][Full Text] [Related]
11. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways. Li Y; Chen F; Chen J; Chan S; He Y; Liu W; Zhang G Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935835 [TBL] [Abstract][Full Text] [Related]
12. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells. Wen Y; Chen H; Zhang L; Wu M; Zhang F; Yang D; Shen J; Chen J Free Radic Biol Med; 2021 Sep; 173():41-51. PubMed ID: 34271106 [TBL] [Abstract][Full Text] [Related]
13. Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes. Hassani S; Ghaffari P; Chahardouli B; Alimoghaddam K; Ghavamzadeh A; Alizadeh S; Ghaffari SH Biomed Pharmacother; 2018 Mar; 99():561-569. PubMed ID: 29902866 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940 [TBL] [Abstract][Full Text] [Related]
15. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway. Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells. Chen GS; Chen SY; Liu ST; Hsieh CC; Lee SP; Huang SM Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012403 [TBL] [Abstract][Full Text] [Related]
17. Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma. Morrison BW; Doudican NA; Patel KR; Orlow SJ Melanoma Res; 2010 Feb; 20(1):11-20. PubMed ID: 19966593 [TBL] [Abstract][Full Text] [Related]
18. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer. Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080 [No Abstract] [Full Text] [Related]
19. Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation. Kim JY; Lee N; Kim YJ; Cho Y; An H; Oh E; Cho TM; Sung D; Seo JH Cancer Lett; 2017 Feb; 386():151-160. PubMed ID: 27894956 [TBL] [Abstract][Full Text] [Related]
20. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells. Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]